Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
Open accessAbstract
We have designed a novel non-antibody scaffold protein, termed Adhiron, based on a phytocystatin consensus sequence. The Adhiron scaffold shows high thermal stability (Tm ca. 101°C), and is expressed well in Escherichia coli. We have determined the X-ray crystal structure of the Adhiron scaffold to 1.75 Å resolution revealing a compact cystatin-like fold. We have constructed a phage-display library in this scaffold by insertion of two variable peptide regions. The library is of high quality and complexity comprising 1.3 × 10(10) clones. To demonstrate library efficacy, we screened against the yeast Small Ubiquitin-like Modifier (SUMO). In selected clones, variable region 1 often contained sequences homologous to the known SUMO interactive motif (V/I-X-V/I-V/I). Four Adhirons were further characterised and displayed low nanomolar affinities and high specificity for yeast SUMO with essentially no cross-reactivity to human SUMO protein isoforms. We have identified binders against >100 target molecules to date including as examples, a fibroblast growth factor (FGF1), platelet endothelial cell adhesion molecule (PECAM-1; CD31), the SH2 domain Grb2 and a 12-aa peptide. Adhirons are highly stable and well expressed allowing highly specific binding reagents to be selected for use in molecular recognition applications.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
POI-targeting polypeptides can either be single chain antibodies (e.g. nanobodies) or a variety of synthetic polypeptide scaffolds that bind POIs such as monobodies, DARPINs, affimers, or Affibodies.
“These POI-targeting polypeptides can either be single chain antibodies (e.g. variable domains from camelid or shark-derived heavy chain only antibodies, nanobodies), or a variety of synthetic polypeptide scaffolds that bind POIs such as fibronectin type III domain-based monobodies [110, 111], designed ankyrin repeats (DARPINs) [112, 113], cystatin-derived affimers [114] or Affibodies derived from”
From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. D. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 27,510 · see citing works
<i>Phaser</i> crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · see citing works
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463 · see citing works
REFMAC 5 for the refinement of macromolecular crystal structures
Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M., Long, F., & Vagin, A. A. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911001314 · Cited by 8,385 · see citing works
Multiple sequence alignment with hierarchical clustering.
Corpet, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.22.10881 · Cited by 5,575 · see citing works
Towards automated crystallographic structure refinement with <i>phenix.refine</i>
Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., & Adams, P. D. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001308 · Cited by 5,511 · see citing works
Scaling and assessment of data quality
Evans, P. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905036693 · Cited by 4,391 · see citing works
Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction
Horton, R. M., Cai, Z., Ho, S. N., & Pease, L. R. (2013) · BioTechniques · doi:10.2144/000114017 · Cited by 1,292 · see citing works
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P. J., & Winter, G. P. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4133 · Cited by 1,019 · see citing works
Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wölle, J., Plückthun, A., & Virnekäs, B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3444 · Cited by 728 · see citing works
Bode, W., Engh, R. A., Müsil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., & Türk, V. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03109.x · Cited by 591 · see citing works
Binz, H. K., Stumpp, M. T., Forrer, P., Amstutz, P., & Plückthun, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00896-9 · Cited by 589 · see citing works
Identification of a SUMO-binding motif that recognizes SUMO-modified proteins
Song, J., Durrin, L. K., Wilkinson, T. A., Krontiris, T. G., & Chen, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403498101 · Cited by 588 · see citing works
The fibronectin type III domain as a scaffold for novel binding proteins
Koide, A., Bailey, C. W., Huang, X., & Koide, S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2238 · Cited by 585 · see citing works
Stubbs, M. T., Laber, B., Bode, W., Huber, R., Jerala, R., Lenar≷cic̆, B., & Türk, V. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08321.x · Cited by 494 · see citing works
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 467 · see citing works
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Schellenberger, V., Wang, C., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1588 · Cited by 462 · see citing works
SUMO junction—what's your function?
Kerscher, O. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400980 · Cited by 418 · see citing works
A roadmap to generate renewable protein binders to the human proteome
Renewable Protein Binder Working Group, Colwill, K., & Gräslund, S. (2011) · Nature Methods · doi:10.1038/nmeth.1607 · Cited by 378 · see citing works
Consensus-derived structural determinants of the ankyrin repeat motif
Mosavi, L. K., Minor, D. L., & Peng, Z. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252537899 · Cited by 360 · see citing works
Sequence Statistics Reliably Predict Stabilizing Mutations in a Protein Domain
Steipe, B., Schiller, B., Plückthun, A., et al. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1434 · Cited by 349 · see citing works
Engineered protein scaffolds as next-generation antibody therapeutics
Gebauer, M., & Skerra, A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.627 · Cited by 339 · see citing works
Alternative non-antibody scaffolds for molecular recognition
Skerra, A. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.04.010 · Cited by 300 · see citing works
A combinatorial library of an α-helical bacterial receptor domain
Nord, K., Nilsson, J., Nilsson, B., et al. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.6.601 · Cited by 287 · see citing works
Designed to be stable: Crystal structure of a consensus ankyrin repeat protein
Kohl, A., Binz, H. K., Forrer, P., Stumpp, M. T., Plückthun, A., & Grütter, M. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337680100 · Cited by 279 · see citing works
Design of Stable α-Helical Arrays from an Idealized TPR Motif
Main, E. R. G., Xiong, Y., Cocco, M. J., D’Andrea, L. D., & Regan, L. (2003) · Structure · doi:10.1016/s0969-2126(03)00076-5 · Cited by 274 · see citing works
Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
Steiner, D., Forrer, P., & Plückthun, A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.085 · Cited by 272 · see citing works
Small Ubiquitin-like Modifier (SUMO) Recognition of a SUMO Binding Motif
Song, J., Zhang, Z., Hu, W., & Chen, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507059200 · Cited by 264 · see citing works
Walter, T. S., Diprose, J. M., Mayo, C., Siebold, C., Pickford, M. G., Carter, L. G., Sutton, G. C., Berrow, N. S., Brown, J., Berry, I. M., et al. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905007808 · Cited by 246 · see citing works
Self-citationLehmann, M., Kostrewa, D., Wyss, M., et al. (2000) · Protein Engineering Design and Selection · doi:10.1093/protein/13.1.49 · Cited by 195 · see citing works
Folding and Unfolding Mechanism of Highly Stable Full-Consensus Ankyrin Repeat Proteins
Wetzel, S. K., Settanni, G., Kenig, M., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.046 · Cited by 179 · see citing works
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain
Wojcik, J. B., Hantschel, O. D., Grebien, F., Kaupe, I., Bennett, K. L., Barkinge, J. L., Jones, R. B., Koide, A., Superti‐Furga, G., & Koide, S. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1793 · Cited by 165 · see citing works
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
Grebien, F., Hantschel, O. D., Wojcik, J. B., Kaupe, I., Kovačic, B., Wyrzucki, A. M., Gish, G. D., Cerny‐Reiterer, S., Koide, A., Beug, H., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.046 · Cited by 152 · see citing works
Lee, S., Park, K., Han, J., Lee, J., Kim, H. S., Hong, S. P., Heu, W., Kim, Y. J., Ha, J., Lee, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113193109 · Cited by 146 · see citing works
Schweizer, A., Roschitzki‐Voser, H., Amstutz, P., Briand, C., Gulotti-Georgieva, M., Prenosil, E., Binz, H. K., Capitani, G., Baici, A., Plückthun, A., et al. (2007) · Structure · doi:10.1016/j.str.2007.03.014 · Cited by 130 · see citing works
Nagata, K., Kudo, N., Abe, K., Arai, S., & Tanokura, M. (2000) · Biochemistry · doi:10.1021/bi0006971 · Cited by 112 · see citing works
Poly-Small Ubiquitin-like Modifier (PolySUMO)-binding Proteins Identified through a String Search
Sun, H., & Hunter, T. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410985 · Cited by 104 · see citing works
Wurch, T., Pierré, A., & Depil, S. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.07.006 · Cited by 102 · see citing works
Consensus Design of Repeat Proteins
Forrer, P., Binz, H. K., Stumpp, M. T., & Plückthun, A. (2004) · ChemBioChem · doi:10.1002/cbic.200300762 · Cited by 102 · see citing works
Reichert, J. M. (2010) · mAbs · doi:10.4161/mabs.2.1.10677 · Cited by 91 · see citing works
Design of novel FN3 domains with high stability by a consensus sequence approach
Jacobs, S. A., Diem, M., Luo, J., et al. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr064 · Cited by 84 · see citing works
Kondo, H., Abe, K., Emori, Y., et al. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80090-p · Cited by 66 · see citing works
Parizek, P., Kummer, L., Rube, P., Prinz, A., Herberg, F. W., & Plückthun, A. (2012) · ACS Chemical Biology · doi:10.1021/cb3001167 · Cited by 65 · see citing works
Highly thermostable fungal cellobiohydrolase I (Cel7A) engineered using predictive methods
Komor, R. S., Romero, P. A., Xie, C. B., & Arnold, F. H. (2012) · Protein Engineering Design and Selection · doi:10.1093/protein/gzs058 · Cited by 64 · see citing works
Gilbreth, R. N., Truong, K., Madu, I. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102294108 · Cited by 61 · see citing works
Theurillat, J.-P. P., Dreier, B., Nagy‐Davidescu, G., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.103 · Cited by 45 · see citing works
Trinucleotide cassettes increase diversity of T7 phage-displayed peptide library
Krumpe, L. R. H., Schumacher, K. M., McMahon, J. B., et al. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-65 · Cited by 39 · see citing works
Anticalins as an alternative to antibody technology
Schlehuber, S., & Skerra, A. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.11.1453 · Cited by 38 · see citing works
Role of SUMO:SIM-mediated protein–protein interaction in non-homologous end joining
Li, Y., Stark, J. M., Chen, D. J., et al. (2010) · Oncogene · doi:10.1038/onc.2010.108 · Cited by 32 · see citing works
Solution Structure of a Phytocystatin from Ananas comosus and Its Molecular Interaction with Papain
Irene, D., Chung, T., Chen, B.-J., Liu, T., Li, F., Tzen, J. T. C., Wang, C., & Chyan, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047865 · Cited by 17 · see citing works
Engineered protein inhibitors of proteases.
Nixon, A. E., & Wood, C. R. (2006) · PubMed · Cited by 16 · see citing works
Flagged first, then by citations
Research works printed but not linked: 51
- Afonine P.V. Grosse-Kunstleve R.W. Echols N. Acta Crystallogr. D 2012 68 352 367 22505256 PMC3322595
- Binz H.K. Stumpp M.T. Forrer P. Amstutz P. Pluckthun A. J. Mol. Biol. 2003 332 489 503 12948497
- Bode W. Engh R. Musil D. Thiele U. Huber R. Karshikov A. Brzin J. Kos J. Turk V. EMBO J. 1988 7 2593 2599 3191914 PMC457133
- Carter P.J. Exp. Cell Res. 2011 317 1261 1269 21371474
- Colwill K. Graslund S. Renewable Prot Binder Working G. Nat. Methods 2011 8 551 558 21572409
- Corpet F. Nucleic Acids Res 1988 16 10881 10890 2849754 PMC338945
- Emsley P. Lohkamp B. Scott W.G. Cowtan K. Acta Crystallogr. D 2010 66 486 501 20383002 PMC2852313
- Evans P.R. Acta Crystallogr. D 2006 62 72 82 16369096
- Forrer P. Binz H.K. Stumpp M.T. Pluckthun A. Chembiochem 2004 5 183 189 14760739
- Gebauer M. Skerra A. Curr. Opin. Chem. Biol. 2009 13 245 255 19501012
- Gilbreth R.N. Truong K. Madu I. Koide A. Wojcik J.B. Li N.-S. Piccirilli J.A. Chen Y. Koide S. Proc. Natl. Acad. Sci. USA 2011 108 7751 7756 21518904 PMC3093456
- Grebien F. Hantschel O. Wojcik J. Cell 2011 147 306 319 22000011 PMC3202669
- Hoogenboom H.R. Griffiths A.D. Johnson K.S. Chiswell D.J. Hudson P. Winter G. Nucleic Acids Res. 1991 19 4133 4137 1908075 PMC328552
- Horton R. Cai Z. Ho S. Pease L. Biotechniques 1990 8 528 535 2357375
- Irene D. Chung T.-Y. Chen B.-J. Liu T.-H. Li F.-Y. Tzen J.T.C. Wang C.-I. Chyan C.L. PLoS ONE 2012 7 e47865 23139757 PMC3490968
- Jacobs S.A. Diem M.D. Luo J. Teplyakov A. Obmolova G. Malia T. Gilliland G.L. O'Neil K.T. PEDS 2012 25 107 117 22240293
- Kabsch W. Acta Crystallogr. D 2010 66 125 132 20124692 PMC2815665
- Kerscher O. EMBO Rep. 2007 8 550 555 17545995 PMC2002525
- Knappik A. Ge L.M. Honegger A. J. Mol. Biol. 2000 296 57 86 10656818
- Kohl A. Binz H.K. Forrer P. Stumpp M.T. Pluckthun A. Grutter M.G. Proc. Natl Acad. Sci. USA 2003 100 1700 1705 12566564 PMC149896
- Koide A. Bailey C.W. Huang X.L. Koide S. J. Mol. Biol. 1998 284 1141 1151 9837732
- Komor R.S. Romero P.A. Xie C.B. Arnold F.H. PEDS 2012 25 827 833 22961332
- Kondo H. Abe K. Emori Y. Arai S. FEBS Lett. 1991 278 87 90 1993479
- Krumpe L.R. Schumacher K.M. McMahon J.B. Makowski L. Mori T. BMC Biotechnol. 2007 7 65 17919322 PMC2174457
- Lee S.-C. Park K. Han J. Proc. Natl. Acad. Sci. USA 2012 109 3299 3304 22328160 PMC3295290
- Lehmann M. Kostrewa D. Wyss M. Brugger R. D'Arcy A. Pasamontes L. van Loon A. Protein Eng 2000 13 49 57 10679530
- Li Y.J. Stark J.M. Chen D.J. Ann D.K. Chen Y. Oncogene 2010 29 3509 3518 20400978 PMC2891878
- Main E.R.G. Xiong Y. Cocco M.J. D'Andrea L. Regan L. Structure 2003 11 497 508 12737816
- McCoy A.J. Grosse-Kunstleve R.W. Adams P.D. Winn M.D. Storoni L.C. Read R.J. J. Appl. Crystallogr. 2007 40 658 674 19461840 PMC2483472
- Mosavi L.K. Minor D.L. Peng Z.Y. Proc. Natl Acad. Sci. USA 2002 99 16029 16034 12461176 PMC138559
- Murshudov G.N. Skubak P. Lebedev A.A. Pannu N.S. Steiner R.A. Nicholls R.A. Winn M.D. Long F. Vagin A.A. Acta Crystallogr. D 2011 67 355 367 21460454 PMC3069751
- Nagata K. Kudo N. Abe K. Arai S. Tanokura M. Biochemistry 2000 39 14753 14760 11101290
- Nixon A.E. Wood C.R. Curr. Opin. Drug Discov. Develop. 2006 9 261 268 16566296
- Nord K. Nilsson J. Nilsson B. Uhlen M. Nygren P.A. Protein Eng. 1995 8 601 608 8532685
- Parizek P. Kummer L. Rube P. Prinz A. Herberg F.W. Plueckthun A. ACS Chem. Biol. 2012 7 1356 1366 22568706
- Reichert J.M. MAbs 2010 2 84 100 20065640 PMC2828582
- Schellenberger V. Wang C.-w. Geething N.C. Nat Biotechnol. 2009 27 1186 1190 19915550
- Schlehuber S. Skerra A. Expert Opin. Biol. Ther. 2005 5 1453 1462 16255649
- Schweizer A. Roschitzki-Voser H. Amstutz P. Structure 2007 15 625 636 17502107
- Skerra A. Curr. Opin. Biotechnol. 2007 18 295 304 17643280
- Song J. Durrin L.K. Wilkinson T.A. Krontiris T.G. Chen Y.A. Proc. Natl Acad. Sci. USA 2004 101 14373 14378 15388847 PMC521952
- Song J. Zhang Z.M. Hu W.D. Chen Y. J. Biol. Chem. 2005 280 40122 40129 16204249
- Steiner D. Forrer P. Plueckthun A. J. Mol. Biol. 2008 382 1211 1227 18706916
- Steipe B. Schiller B. Pluckthun A. Steinbacher S. J. Mol. Biol. 1994 240 188 192 8028003
- Stubbs M.T. Laber B. Bode W. Huber R. Jerala R. Lenarcic B. Turk V. EMBO J. 1990 9 1939 1947 2347312 PMC551902
- Sun H. Hunter T. J. Biol. Chem. 2012 287 42071 42083 23086935 PMC3516753
- Theurillat J.-P. Dreier B. Nagy-Davidescu G. Seifert B. Behnke S. Zuerrer-Haerdi U. Ingold F. Plueckthun A. Moch H. Mod. Pathol. 2010 23 1289 1297 20495541
- Walter T.S. Diprose J.M. Mayo C.J. Acta Crystallogr. D 2005 61 651 657 15930615 PMC7159505
- Wetzel S.K. Settanni G. Kenig M. Binz H.K. Pluckthun A. J. Mol. Biol. 2008 376 241 257 18164721
- Wojcik J. Hantschel O. Grebien F. Nat. Struct. Mol. Biol. 2010 17 519 U173 20357770 PMC2926940
- Wurch T. Pierre A. Depil S. Trends Biotechnol. 2012 30 575 582 22944617
Cited by
Sorted by citations
Advances in targeted degradation of endogenous proteins
Röth, S., Fulcher, L. J., & Sapkota, G. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03112-6 · Cited by 92 · see citing works
Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J. (2017) · Chemical Science · doi:10.1039/c7sc00388a · Cited by 39 · see citing works
- Authors
- Tiede, C., Tang, A. A. S., Deacon, S. E., Mandal, U., Nettleship, J. E., Owen, R. L., George, S. E., Harrison, D. J., Owens, R. J., Tomlinson, D. C., & McPherson, M. J.
- Affiliations
- University of Leeds (GB)
- Rutherford Appleton Laboratory (GB)
- Diamond Light Source (GB)
- Corresponding author
- Tomlinson, Darren C.
- McPherson, Michael J.
- ORCID
- Venue
- Protein Engineering, Design and Selection
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-25
- Volume
- 27
- Issue
- 5
- Pages
- 145-155
- ISSN
- 0269-2139 (ISSN-L)
- 1741-0134
- 1741-0126
- PMC
- PMC4000234
- OpenAlex
- W2141002805
- Cited by
- 163
- References
- 51
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 16 · 2022: 13 · 2021: 16 · 2020: 21 · 2019: 17 · 2018: 12 · 2017: 20 · 2016: 8 · 2015: 11 · 2014: 4
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Protein Engineering Design and Selection (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Huddersfield Repository (University of Huddersfield) (acceptedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (/WT088908/Z/09/Z, 088908/Z/09/Z)
- University of Leeds
- Directorate for Biological Sciences
- Medical Research Council (MR/K018779/1)
- Engineering and Physical Sciences Research Council (088908/Z/09/Z, WT 088908/Z/09/Z)
- Biotechnology and Biological Sciences Research Council (24/G15882)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Keywords
- phage display library, thermal stability, SUMO, protein-protein binding, fibroblast growth factor 1, CD31, Grb2 SH2 domain, molecular recognition, X-ray crystal structure
- MeSH terms
- Amino Acid Sequence, Base Sequence, Humans, Models, Molecular, Molecular Sequence Data, Peptides, Temperature, Protein Engineering, Cystatins, Consensus Sequence, Protein Structure, Secondary, Peptide Library, SUMO-1 Protein, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review